ValuEngine upgraded shares of Surgery Partners (NASDAQ:SGRY) from a hold rating to a buy rating in a research note published on Thursday morning.

SGRY has been the topic of a number of other reports. Stifel Nicolaus raised Surgery Partners from a sell rating to a hold rating and set a $15.00 price objective on the stock in a research report on Thursday, June 28th. Zacks Investment Research raised Surgery Partners from a sell rating to a hold rating in a research report on Thursday, April 12th. BidaskClub raised Surgery Partners from a hold rating to a buy rating in a research report on Friday, May 4th. Finally, Leerink Swann started coverage on Surgery Partners in a research report on Tuesday, August 7th. They set an outperform rating and a $20.00 price objective on the stock. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company has an average rating of Buy and an average price target of $18.50.

Shares of Surgery Partners traded up $0.80, reaching $17.80, during trading hours on Thursday, MarketBeat.com reports. 608,840 shares of the company traded hands, compared to its average volume of 339,499. Surgery Partners has a 12-month low of $7.10 and a 12-month high of $19.95. The company has a quick ratio of 1.55, a current ratio of 1.72 and a debt-to-equity ratio of 1.63. The stock has a market cap of $831.52 million, a P/E ratio of -21.19 and a beta of 1.78.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Thursday, August 9th. The company reported ($0.18) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.07. Surgery Partners had a negative return on equity of 1.65% and a negative net margin of 5.56%. The firm had revenue of $444.78 million for the quarter, compared to analysts’ expectations of $428.50 million. During the same period in the previous year, the firm earned ($0.09) EPS. The business’s quarterly revenue was up 54.2% on a year-over-year basis. equities research analysts expect that Surgery Partners will post -0.55 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently bought and sold shares of SGRY. Point72 Asset Management L.P. purchased a new position in Surgery Partners in the 1st quarter worth approximately $6,097,000. NN Investment Partners Holdings N.V. lifted its holdings in Surgery Partners by 4.8% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 5,523,801 shares of the company’s stock worth $82,305,000 after purchasing an additional 250,704 shares in the last quarter. BNP Paribas Arbitrage SA lifted its holdings in Surgery Partners by 2,564.5% in the 1st quarter. BNP Paribas Arbitrage SA now owns 104,021 shares of the company’s stock worth $1,784,000 after purchasing an additional 100,117 shares in the last quarter. Millennium Management LLC purchased a new position in Surgery Partners in the 1st quarter worth approximately $814,000. Finally, BlackRock Inc. lifted its holdings in Surgery Partners by 3.6% in the 2nd quarter. BlackRock Inc. now owns 1,338,176 shares of the company’s stock worth $19,939,000 after purchasing an additional 46,111 shares in the last quarter. 97.77% of the stock is currently owned by institutional investors.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

See Also: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.